Related Experiment Video
Updated: Jun 2, 2026

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing
David Ramonet1, João Paulo L Daher, Brian M Lin
1Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Abstract:
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene cause late-onset, autosomal dominant familial Parkinson's disease (PD) and also contribute to idiopathic PD. LRRK2 mutations represent the most common cause of PD with clinical and neurochemical features that are largely indistinguishable from idiopathic disease. Currently, transgenic mice expressing wild-type or disease-causing mutants of LRRK2 have failed to produce overt neurodegeneration, although abnormalities in nigrostriatal dopaminergic neurotransmission have been observed. Here, we describe the development and characterization of transgenic mice expressing human LRRK2 bearing the familial PD mutations, R1441C and G2019S. Our study demonstrates that expression of G2019S mutant LRRK2 induces the degeneration of nigrostriatal pathway dopaminergic neurons in an age-dependent manner. In addition, we observe autophagic and mitochondrial abnormalities in the brains of aged G2019S LRRK2 mice and markedly reduced neurite complexity of cultured dopaminergic neurons. These new LRRK2 transgenic mice will provide important tools for understanding the mechanism(s) through which familial mutations precipitate neuronal degeneration and PD.
Insights
New transgenic mice expressing G2019S mutant LRRK2 show age-dependent degeneration of dopaminergic neurons, offering a tool to study Parkinson's disease mechanisms. These models reveal autophagic and mitochondrial issues, aiding Parkinson's disease (PD) research.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Mutations in leucine-rich repeat kinase 2 (LRRK2) are a leading genetic cause of Parkinson's disease (PD).
- Existing LRRK2 transgenic mouse models have not fully recapitulated PD neurodegeneration.
- LRRK2 mutations are linked to both familial and idiopathic forms of PD.
Purpose of the Study:
- To develop and characterize novel transgenic mice expressing familial Parkinson's disease (PD) mutations in LRRK2.
- To investigate the impact of G2019S and R1441C LRRK2 mutations on nigrostriatal dopaminergic neurons.
- To establish a more accurate animal model for studying PD pathogenesis.
Main Methods:
- Generation of transgenic mice expressing human LRRK2 with R1441C and G2019S mutations.
- Age-dependent assessment of neurodegeneration in the nigrostriatal pathway.
- Analysis of autophagic and mitochondrial function in aged G2019S LRRK2 mice.
- Evaluation of neurite complexity in cultured dopaminergic neurons.
Main Results:
- Expression of G2019S mutant LRRK2 induced age-dependent degeneration of nigrostriatal dopaminergic neurons.
- Aged G2019S LRRK2 mice exhibited autophagic and mitochondrial abnormalities.
- Cultured dopaminergic neurons from these mice showed reduced neurite complexity.
Conclusions:
- The developed G2019S LRRK2 transgenic mice serve as a valuable tool for Parkinson's disease (PD) research.
- These mice demonstrate key pathological features relevant to PD, including neuronal degeneration and cellular dysfunction.
- Further study of these models will elucidate mechanisms underlying LRRK2-mediated neurodegeneration in PD.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Lysosomal Hydrolases
Neural Regulation

